{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T18:07:03Z","timestamp":1785002823172,"version":"3.55.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.ijcard.2016.07.038","type":"journal-article","created":{"date-parts":[[2016,7,5]],"date-time":"2016-07-05T18:30:18Z","timestamp":1467743418000},"page":"342-346","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Vascular and metabolic effects of omega-3 fatty acids combined with fenofibrate in patients with hypertriglyceridemia"],"prefix":"10.1016","volume":"221","author":[{"given":"Kwang Kon","family":"Koh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pyung Chun","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Sakuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Hwan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eak Kyun","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2016.07.038_bb0005","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijcard.2012.03.127","article-title":"How to control residual cardiovascular risk despite statin treatment: focusing on HDL\u2013cholesterol","volume":"166","author":"Lim","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.038_bb0010","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.jacc.2015.07.072","article-title":"How to control residual risk during statin era?","volume":"66","author":"Koh","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.038_bb0015","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4070\/kcj.2016.46.2.135","article-title":"Hypertriglyceridemia and cardiovascular diseases: revisited","volume":"46","author":"Han","year":"2016","journal-title":"Korean Circ. J."},{"key":"10.1016\/j.ijcard.2016.07.038_bb0020","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.2337\/dc10-2109","article-title":"Increasing prevalence of metabolic syndrome in Korea: the Korean National Health and Nutrition Examination Survey for 1998\u20132007","volume":"34","author":"Lim","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijcard.2016.07.038_bb0025","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4070\/kcj.2015.45.2.141","article-title":"Effects of age, sex, and menopausal status on blood cholesterol profile in the Korean population","volume":"45","author":"Park","year":"2015","journal-title":"Korean Circ. J."},{"key":"10.1016\/j.ijcard.2016.07.038_bb0030","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0140-6736(14)61177-6","article-title":"Triglycerides and cardiovascular disease","volume":"384","author":"Nordestgaard","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2016.07.038_bb0035","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/S0140-6736(10)60656-3","article-title":"Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis","volume":"375","author":"Jun","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2016.07.038_bb0040","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijcard.2007.04.080","article-title":"Vascular and metabolic effects of treatment of combined hyperlipidemia: focus on statins and fibrates","volume":"124","author":"Koh","year":"2008","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.038_bb0045","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0140-6736(99)07072-5","volume":"354","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2016.07.038_bb0050","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1093\/eurheartj\/ehn294","article-title":"Long-term fish consumption and n\u22123 fatty acid intake in relation to (sudden) coronary heart disease death: the Zutphen study","volume":"29","author":"Streppel","year":"2008","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2016.07.038_bb0055","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1586\/14779072.6.3.391","article-title":"Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications","volume":"6","author":"Bays","year":"2008","journal-title":"Expert. Rev. Cardiovasc. Ther."},{"key":"10.1016\/j.ijcard.2016.07.038_bb0060","doi-asserted-by":"crossref","first-page":"808","DOI":"10.3945\/ajcn.2009.28374","article-title":"Effects of n\u22123 fatty acids on macro- and microvascular function in subjects with type 2 diabetes mellitus","volume":"91","author":"Stirban","year":"2010","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.ijcard.2016.07.038_bb0065","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.atherosclerosis.2011.11.018","article-title":"Significant differential effects of omega-3 fatty acids and fenofibrate in patients with hypertriglyceridemia","volume":"220","author":"Koh","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2016.07.038_bb0070","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.ijcard.2014.07.075","article-title":"Omega-3 fatty acid therapy dose-dependently and significantly decreased triglycerides and improved flow-mediated dilation, however, did not significantly improve insulin sensitivity in patients with hypertriglyceridemia","volume":"176","author":"Oh","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.038_bb0075","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1161\/01.CIR.0000143085.86697.13","article-title":"Additive beneficial effects of losartan combined with simvastatin in the treatment of hypercholesterolemic, hypertensive patients","volume":"110","author":"Koh","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.07.038_bb0080","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.2337\/diacare.28.6.1419","article-title":"Beneficial effects of fenofibrate to improve endothelial dysfunction and raise adiponectin levels in patients with primary hypertriglyceridemia","volume":"28","author":"Koh","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijcard.2016.07.038_bb0085","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jacc.2009.10.053","article-title":"Atorvastatin causes insulin resistance and increases ambient glycemia in hypercholesterolemic patients","volume":"55","author":"Koh","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.038_bb0090","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.2337\/db13-0566","article-title":"Combination pravastatin and valsartan treatment has additive beneficial effects to simultaneously improve both metabolic and cardiovascular phenotypes beyond that of monotherapy with either drug in patients with primary hypercholesterolemia","volume":"62","author":"Koh","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.ijcard.2016.07.038_bb0095","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1210\/jcem.85.7.6661","article-title":"Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans","volume":"85","author":"Katz","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ijcard.2016.07.038_bb0100","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1152\/ajpendo.00645.2007","article-title":"Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage","volume":"294","author":"Muniyappa","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ijcard.2016.07.038_bb0105","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.jacc.2005.02.052","article-title":"Additive beneficial effects of fenofibrate combined with atorvastatin in the treatment of patients with combined hyperlipidemia","volume":"45","author":"Koh","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.038_bb0110","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2337\/diacare.29.02.06.dc05-1418","article-title":"Additive beneficial effects of fenofibrate combined with candesartan in the treatment of hypertriglyceridemic, hypertensive patients","volume":"29","author":"Koh","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijcard.2016.07.038_bb0115","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1161\/01.HYP.0000187900.36455.4c","article-title":"Beneficial vascular and metabolic effects of peroxisome proliferator-activated receptor (PPAR)\u03b1 activators","volume":"46","author":"Han","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2016.07.038_bb0120","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.2337\/diabetes.54.12.3358","article-title":"Peroxisome proliferator-activated receptor (PPAR)alpha activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPARalpha, PPARgamma, and their combination","volume":"54","author":"Tsuchida","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.ijcard.2016.07.038_bb0125","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.2337\/dc07-0015","article-title":"Fenofibrate therapy ameliorates fasting and postprandial lipoproteinemia, oxidative stress, and the inflammatory response in subjects with hypertriglyceridemia and the metabolic syndrome","volume":"30","author":"Rosenson","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijcard.2016.07.038_bb0130","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1161\/CIRCULATIONAHA.105.563213","article-title":"Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms","volume":"113","author":"Kim","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.07.038_bb0135","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/MOL.0b013e328012b627","article-title":"Reciprocal relationships between abnormal metabolic parameters and endothelial dysfunction","volume":"18","author":"Han","year":"2007","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.ijcard.2016.07.038_bb0140","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1056\/NEJMoa1001282","article-title":"Effects of combination lipid therapy in type 2 diabetes mellitus","volume":"362","author":"ACCORD Study Group","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2016.07.038_bb0145","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1001288","article-title":"Effects of medical therapies on retinopathy progression in type 2 diabetes","volume":"363","author":"Chew","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2016.07.038_bb0150","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0140-6736(07)60527-3","article-title":"Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis","volume":"369","author":"Yokoyama","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2016.07.038_bb0155","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0140-6736(08)61239-8","article-title":"Effect of n\u22123 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial","volume":"372","author":"Gissi-HF Investigators","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2016.07.038_bb0160","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1161\/CIRCULATIONAHA.110.948562","article-title":"OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline adjusted therapy after myocardial infarction","volume":"122","author":"Rauch","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.07.038_bb0165","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1056\/NEJMoa1003603","article-title":"n\u22123 fatty acids and cardiovascular events after myocardial infarction","volume":"363","author":"Kromhout","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2016.07.038_bb0170","doi-asserted-by":"crossref","first-page":"5457","DOI":"10.1210\/jcem.86.11.7880","article-title":"Repeatability characteristics of simple indices of insulin resistance: implications for research applications","volume":"86","author":"Mather","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ijcard.2016.07.038_bb0175","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1210\/jcem.87.6.8592","article-title":"QUICKI is useful for following improvements in insulin sensitivity after therapy in patients with type 2 diabetes mellitus","volume":"87","author":"Katsuki","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ijcard.2016.07.038_bb0180","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2337\/diabetes.52.2.463","article-title":"Prediction of type 2 diabetes using simple measures of insulin resistance: combined results from the San Antonio Heart Study, the Mexico City Diabetes Study, and the Insulin Resistance Atherosclerosis Study","volume":"52","author":"Hanley","year":"2003","journal-title":"Diabetes"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316313894?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316313894?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T14:24:58Z","timestamp":1536589498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527316313894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":36,"alternative-id":["S0167527316313894"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.07.038","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vascular and metabolic effects of omega-3 fatty acids combined with fenofibrate in patients with hypertriglyceridemia","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.07.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}